Barington/Hilco Acquisition (BHAC) - Total Liabilities
Based on the latest financial reports, Barington/Hilco Acquisition (BHAC) has total liabilities worth $9.74 Million USD as of March 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Barington/Hilco Acquisition (BHAC) net asset momentum to track the company's year-over-year net asset growth rate.
Barington/Hilco Acquisition - Total Liabilities Trend (2015–2024)
This chart illustrates how Barington/Hilco Acquisition's total liabilities have evolved over time, based on quarterly financial data. See BHAC free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Barington/Hilco Acquisition Competitors by Total Liabilities
The table below lists competitors of Barington/Hilco Acquisition ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
OncoCyte Corp
NASDAQ:OCX
|
USA | $50.14 Million |
|
Micropolis Holding Company
NYSE MKT:MCRP
|
USA | $40.58 Million |
|
Bon Fame Co Ltd
TWO:8433
|
Taiwan | NT$2.41 Billion |
|
Eaton Vance Senior Income Closed Fund
NYSE:EVF
|
USA | $24.06 Million |
|
DHI Group Inc
NYSE:DHX
|
USA | $95.20 Million |
|
Edel SE & Co. KGaA
F:EDL
|
Germany | €162.51 Million |
|
Mercan Kimya Sanayi ve Ticaret AS
IS:MERCN
|
Turkey | TL1.44 Billion |
|
Bioton S.A.
WAR:BIO
|
Poland | zł170.59 Million |
Liability Composition Analysis (2015–2024)
This chart breaks down Barington/Hilco Acquisition's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see BHAC stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.00 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.37 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.70 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Barington/Hilco Acquisition's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Barington/Hilco Acquisition (2015–2024)
The table below shows the annual total liabilities of Barington/Hilco Acquisition from 2015 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $8.22 Million | +185.11% |
| 2023-12-31 | $2.88 Million | -72.70% |
| 2022-12-31 | $10.56 Million | -37.94% |
| 2021-12-31 | $17.01 Million | +72.73% |
| 2017-12-31 | $9.85 Million | -74.71% |
| 2016-12-31 | $38.95 Million | +0.15% |
| 2015-12-31 | $38.90 Million | -- |
About Barington/Hilco Acquisition
As of June 6, 2025, Focus Impact BH3 Acquisition Company was acquired by XCF Global Capital, Inc., in a reverse merger transaction. Focus Impact BH3 Acquisition Company does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was forme… Read more